A clearer way to recognize the transition and prepare for a better conversation with your clinician.

Nobody told us it starts this early

Most of us grew up thinking menopause was something that happened in our 50s: the periods stop, the hot flashes start, and that's that. What nobody explained is that the hormonal shift often begins years earlier, sometimes in our early-to-mid 40s, and it rarely announces itself with a hot flash.

Instead, it shows up as a string of changes that seem unrelated. You're sleeping worse. Your cycle is suddenly shorter, heavier, or unpredictable. You feel more anxious or irritable than you recognize in yourself. You walk into a room and forget why. Many women I talk with have been told it's stress, aging, or “just life”—and some have been handed a prescription for one symptom without anyone connecting the dots.

This is the conversation I wish more women had before those years arrive: what perimenopause actually is, how to recognize it, and how to walk into your clinician's office prepared for a more useful visit.

1. Perimenopause is a transition, not an event

Menopause itself is technically a single point in time: 12 months after your last period. The average age in the United States is about 51, and ages 45 to 55 are generally considered typical. Perimenopause is the transition leading up to that point and through the first year after the final menstrual period.

That runway is longer than most women expect. The median length is about four years, but it can last longer. Clinicians describe the stages using STRAW+10, a staging system that relies more heavily on menstrual-cycle patterns than on any single laboratory value.

StageWhat it typically looks like
Late reproductive yearsCycles remain regular, but subtle changes in flow or length may appear; sleep or mood symptoms may begin.
Early perimenopauseCycle length persistently varies by seven or more days from what is normal for you.
Late perimenopauseSkipped periods, including gaps of 60 days or longer.
MenopauseTwelve months with no menstrual period.

The part I wish more women understood: perimenopause is marked by fluctuation, not a smooth, steady decline.

Some months ovulation does not occur, which means little progesterone is produced during that cycle. In other months, estrogen may surge. Those swings—not simply low hormone levels—help explain why you can feel like yourself one week and not the next.

2. The first signs often are not hot flashes

Hot flashes are the symptom everyone expects, so women can miss what comes first. Vasomotor symptoms, including hot flashes and night sweats, often become more common later in the transition. Anxiety, sleep disruption, or cognitive changes may be blamed on stress before anyone considers a hormonal connection.

These are the changes I most want women to have on their radar:

None of these proves you are in perimenopause on its own. Thyroid disorders, iron deficiency from heavy bleeding, sleep apnea, depression, and other conditions can look similar. That is why a thoughtful evaluation matters.

3. A “normal” hormone test does not rule it out

A woman describes months of symptoms, gets one blood test, and is told her hormones are normal. But hormones fluctuate substantially during perimenopause, so a single draw is a snapshot of one day—not a verdict on the entire picture.

Perimenopause is generally a clinical diagnosis based on age, symptoms, and changes in the menstrual cycle rather than one laboratory result. Labs may still help rule out thyroid disease, anemia, iron deficiency, pregnancy, blood-sugar problems, and other possible explanations. Your story provides the context; testing may support the evaluation.

4. How to prepare for a better conversation

A short appointment goes further when your clinician can see the pattern in front of them. Begin tracking two to three months before your visit when possible.

Complete a symptom score before your visit. In my practice, I use the Menopause Rating Scale (MRS) to evaluate quality of life and track changes over time. It is a validated 11-question self-assessment covering vasomotor, cardiac, sleep, mood, anxiety, exhaustion, sexual, bladder, vaginal, and musculoskeletal symptoms. Current patients may receive the authorized form through the practice's clinical intake process before an appointment. If you are working with another clinician, ask whether they use a validated symptom questionnaire you can complete in advance.

Track these for at least two cycles:

Bring your history:

Questions worth asking:

  1. Based on my symptoms and cycle pattern, do you think I am in perimenopause?
  2. What else could be causing this, and do we need testing to rule it out?
  3. What lifestyle, nonhormonal, and hormonal options might apply to me, and what are their individual risks and benefits?
  4. If hormone therapy is not appropriate for me, why not?
  5. How will we determine whether treatment is working, and when should we follow up?

Lead with the symptom that most affects your daily life. If sleep is what is disrupting your life, say that first. It keeps the visit focused on what matters most to you.

5. You have more options than you may have been told

Many women have been told that hormone therapy is too dangerous or that they simply have to endure the transition. Current care calls for a more individualized discussion based on symptoms, age, time since the final menstrual period, health history, preferences, and treatment goals.

ApproachExamplesMay be considered for
FoundationsStrength training, adequate protein, sleep routines, limiting alcohol, and stress careSupporting overall health alongside other appropriate treatment
Cycle-focused optionsMicronized progesterone, a progestin IUD, or low-dose hormonal contraception depending on individual needsHeavy or irregular bleeding, cycle-related symptoms, or contraception
Menopausal hormone therapyEstradiol by patch, gel, spray, or pill, with endometrial protection when a uterus is present; local vaginal therapies may also be consideredVasomotor symptoms, sleep disruption, bone-health considerations, or genitourinary symptoms
Nonhormonal prescriptionsFezolinetant, certain antidepressants, gabapentin, and other individualized optionsWomen who cannot or prefer not to use systemic hormones

Estradiol and micronized progesterone are available in FDA-approved bioidentical formulations; compounded products also exist. Ask your clinician how they choose among formulations and how treatment will be monitored.

6. Do not wait on these

Some changes deserve prompt medical attention:

The bottom line

Perimenopause is not a disease, and it is not something to simply endure. It is a real, predictable transition that deserves the same attention we give to any other stage of health. When you recognize the signs, track your pattern, and arrive with clear questions, you are far more likely to leave with a useful plan.

Continue with Protein, Strength, and the Midlife Body, read about hormones, exercise, and weight loss, explore Resources, or learn about Health Consulting.

This article is for general education and does not establish a clinician-patient relationship or replace individualized medical advice. Talk with your own clinician before starting, stopping, or changing treatment. Read the full disclaimer.

References

  1. Perimenopause: symptoms and management. The Pharmaceutical Journal.
  2. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10. Menopause. 2012;19(4):387-395.
  3. Towards a more accurate global picture of perimenopause. Bulletin of the World Health Organization. 2024.
  4. Emotional and cognitive symptoms are redefining perimenopause recognition. Contemporary OB/GYN. 2026.
  5. Get to know the signs of perimenopause. Mayo Clinic Press.
  6. Perimenopause. The Menopause Society.
  7. Perimenopause: diagnosis and tests. Cleveland Clinic.
  8. Heinemann K, Ruebig A, Potthoff P, et al. The Menopause Rating Scale: a methodological review. Health Qual Life Outcomes. 2004;2:45.
  9. Dinger J, Zimmermann T, Heinemann LAJ, Stoehr D. Quality of life and hormone use: new validation results of MRS scale. Health Qual Life Outcomes. 2006;4:32.
  10. FDA removes menopause hormone therapy black box warnings. Harvard Health Publishing.
  11. FDA approves label changes for first batch of menopausal hormone therapy products. Urology Times. 2026.